Trial Outcomes & Findings for PRESTIGE Observational Study (NCT NCT00875810)

NCT ID: NCT00875810

Last Updated: 2016-01-28

Results Overview

The primary objective is the documentation of QoL before and after cervical disc surgery using the PRESTIGE® Cervical Disc System. The QoL will be determined using the EQ-5D questionnaire and the Neck Disability Index (NDI). EQ-5D is an instrument for measuring health outcome and consists of five dimensions: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression and a Visual Analog Scale that can be used as a quantitative measure of health as judged by the patient. Each dimension has 3 levels (no problems = 1, some problems = 2, and extreme problems = 3). The EQ-5D index has an upper limit of 1 that indicates full health (indicated by "no problem" in all domains), whereas 0 represents death. Scores worst than 0 are possible, implying that some health states may be worse than death.

Recruitment status

COMPLETED

Target enrollment

194 participants

Primary outcome timeframe

2 years

Results posted on

2016-01-28

Participant Flow

Participant milestones

Participant milestones
Measure
Cervical Arthroplasty + Prestige LP
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Overall Study
STARTED
194
Overall Study
Implanted
190
Overall Study
Discharged
177
Overall Study
3 Months Follow up
175
Overall Study
6 Months Follow up
80
Overall Study
12 Months Follow up
112
Overall Study
24 Months Follow up
148
Overall Study
COMPLETED
148
Overall Study
NOT COMPLETED
46

Reasons for withdrawal

Reasons for withdrawal
Measure
Cervical Arthroplasty + Prestige LP
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Overall Study
Withdrawal by Subject
1
Overall Study
Physician Decision
3
Overall Study
Lost to Follow-up
39
Overall Study
Patient enroled but not implanted
2
Overall Study
Device explanted
1

Baseline Characteristics

PRESTIGE Observational Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cervical Arthroplasty + Prestige LP
n=190 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Age, Continuous
43.9 years
STANDARD_DEVIATION 8.6 • n=5 Participants
Sex: Female, Male
Female
127 Participants
n=5 Participants
Sex: Female, Male
Male
63 Participants
n=5 Participants
Region of Enrollment
Serbia
10 participants
n=5 Participants
Region of Enrollment
Saudi Arabia
11 participants
n=5 Participants
Region of Enrollment
Hungary
13 participants
n=5 Participants
Region of Enrollment
Czech Republic
44 participants
n=5 Participants
Region of Enrollment
Slovakia
28 participants
n=5 Participants
Region of Enrollment
Poland
83 participants
n=5 Participants
Region of Enrollment
Kuwait
1 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 years

Population: As this is an observational study not all patients completed EQ-5D questionnaires, for this reason the number of participants analyzed is different from the number of patients in the Participant Flow.

The primary objective is the documentation of QoL before and after cervical disc surgery using the PRESTIGE® Cervical Disc System. The QoL will be determined using the EQ-5D questionnaire and the Neck Disability Index (NDI). EQ-5D is an instrument for measuring health outcome and consists of five dimensions: mobility, selfcare, usual activities, pain/discomfort, and anxiety/depression and a Visual Analog Scale that can be used as a quantitative measure of health as judged by the patient. Each dimension has 3 levels (no problems = 1, some problems = 2, and extreme problems = 3). The EQ-5D index has an upper limit of 1 that indicates full health (indicated by "no problem" in all domains), whereas 0 represents death. Scores worst than 0 are possible, implying that some health states may be worse than death.

Outcome measures

Outcome measures
Measure
Cervical Arthroplasty + Prestige LP
n=155 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
EQ-5D
Baseline
0.59 units on a scale
Standard Deviation 0.22
EQ-5D
3 months Follow up
0.78 units on a scale
Standard Deviation 0.16
EQ-5D
6 months Follow up
0.77 units on a scale
Standard Deviation 0.20
EQ-5D
12 months Follow up
0.80 units on a scale
Standard Deviation 0.19
EQ-5D
24 months Follow up
0.76 units on a scale
Standard Deviation 0.21

PRIMARY outcome

Timeframe: 2 years

Population: As this is an observational study not all patients completed NDI questionnaires, for this reason the number of participants analyzed is different from the number of patients in the Participant Flow.

The primary objective is the documentation of QoL before and after cervical disc surgery using the PRESTIGE® Cervical Disc System. The QoL will be determined using the EQ-5D questionnaire and the Neck Disability Index (NDI). The NDI is a self-reported questionnaire designed to provide information on how neck pain affects the patient's ability to manage in everyday life. It contains questions on 10 items including pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. NDI results can be presented as a raw score or as a percent. When presenting it as a raw score, each section is scored on a 0 to 5 rating scale and the result is summarized to a total score with a maximum score of 50. This raw score can also be doubled and expressed as a percentage. Zero points or 0% means no activity limitations and 50 points or 100% means complete activity limitation.

Outcome measures

Outcome measures
Measure
Cervical Arthroplasty + Prestige LP
n=155 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Neck Disability Index (NDI) Score
Baseline
24.1 units on a scale
Standard Deviation 8.6
Neck Disability Index (NDI) Score
3 months Follow up
13.2 units on a scale
Standard Deviation 8.9
Neck Disability Index (NDI) Score
6 months Follow up
12.6 units on a scale
Standard Deviation 10.2
Neck Disability Index (NDI) Score
12 months Follow up
12.3 units on a scale
Standard Deviation 10.0
Neck Disability Index (NDI) Score
24 months
13.4 units on a scale
Standard Deviation 10.3

SECONDARY outcome

Timeframe: Baseline visit

Documentation of duration of pain prior to enrollment

Outcome measures

Outcome measures
Measure
Cervical Arthroplasty + Prestige LP
n=190 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Duration of Pain Prior to Enrollment
patients with pain for 3-6 months before surgery
22.1 percentage of patients with pain
Duration of Pain Prior to Enrollment
patients with pain for 6-12 months before surgery
21.3 percentage of patients with pain
Duration of Pain Prior to Enrollment
patients with pain for >12 months before surgery
37.4 percentage of patients with pain

SECONDARY outcome

Timeframe: 2 years

Population: As this is an observational study not all patients had images available for each visit, for this reason the number of participants analyzed is different from the number of patients in the Participant Flow.

Outcome measures

Outcome measures
Measure
Cervical Arthroplasty + Prestige LP
n=96 Participants
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Intervertebral Disc Space
Baseline
0.22 millimiters
Standard Deviation 0.07
Intervertebral Disc Space
3 months Follow up
0.41 millimiters
Standard Deviation 0.15
Intervertebral Disc Space
6 months Follow up
0.42 millimiters
Standard Deviation 0.16
Intervertebral Disc Space
12 months Follow up
0.40 millimiters
Standard Deviation 0.14
Intervertebral Disc Space
24 months Follow up
0.39 millimiters
Standard Deviation 0.13

Adverse Events

Cervical Arthroplasty + Prestige LP

Serious events: 7 serious events
Other events: 40 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Cervical Arthroplasty + Prestige LP
n=190 participants at risk
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
Musculoskeletal and connective tissue disorders
Lumbar pain
1.1%
2/190 • Number of events 3
Nervous system disorders
syndroma carpi radialis
0.53%
1/190 • Number of events 1
Musculoskeletal and connective tissue disorders
Arm pain
0.53%
1/190 • Number of events 1
Musculoskeletal and connective tissue disorders
Quervain syndrome
0.53%
1/190 • Number of events 1
Nervous system disorders
Thoracic spine discopathy
0.53%
1/190 • Number of events 1
General disorders
Wound hematoma
0.53%
1/190 • Number of events 1

Other adverse events

Other adverse events
Measure
Cervical Arthroplasty + Prestige LP
n=190 participants at risk
All patients were subjected to a cervical spinal arthroplasty. A complete discectomy was performed and the PRESTIGE® LP Cervical Disc System was inserted to replace the damaged intervertebral disc.
General disorders
Neck, shoulder and arm pain
12.6%
24/190 • Number of events 25
General disorders
Lumbar pain
8.4%
16/190 • Number of events 18

Additional Information

Cristina Faria

MedtronicSpineECA

Phone: +41 21 802 70 00

Results disclosure agreements

  • Principal investigator is a sponsor employee The sponsor can review results communications prior to public release. The sponsor will limit its review to the determination of whether Confidential Information is disclosed and to check for technical correctness.
  • Publication restrictions are in place

Restriction type: OTHER